ROSE PALAZZO: Open Payments
NPI 1962468413 · KENMORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 26 payments from 11 companies in 2025. Trend: 2023 $1,431 · 2024 $1,521 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $146 |
| MILLICENT US INC | 4 | $87 |
| Astellas Pharma US Inc | 3 | $69 |
| Exeltis, USA Inc. | 3 | $61 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $52 |
| Organon LLC | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| CooperSurgical, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
Products named: Wegovy, Veozah, SLYND, FEMLYV, NEXPLANON, INTRAROSA, MYFEMBREE, Paragard T 380A.
Industry payments across NY — which companies pay providers there.
